Opening book details…
About this Medicine article
Randomized Phase 3 Trial of Regorafenib in Patients (Patients) with Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) Progressing Despite Prior Treatment with at Least Imatinib (IM) and Sunitinib (SU) : Grid Trial by Nishida, T. ;Casali, P.G. ;Reichardt, P. ;Kang, Y.-K. ;Blay, J.-Y. ;Joensuu, H. ;Maki, R.G. ;Rutkowski, P. ;Hohenberger, P. ;Gelderblom, H. ;Leahy, M.G. ;von Mehren, M. ;Schoffski, P. ;Blackstein, M.E. ;Cesne, A.L. ;Badalamenti, G. ;Xu, J.-M. ;Laurent, D. ;Kuss, I. ;Demetri, G.D. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Nishida, T. ;Casali, P.G. ;Reichardt, P. ;Kang, Y.-K. ;Blay, J.-Y. ;Joensuu, H. ;Maki, R.G. ;Rutkowski, P. ;Hohenberger, P. ;Gelderblom, H. ;Leahy, M.G. ;von Mehren, M. ;Schoffski, P. ;Blackstein, M.E. ;Cesne, A.L. ;Badalamenti, G. ;Xu, J.-M. ;Laurent, D. ;Kuss, I. ;Demetri, G.D.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2012
- Field
- Medicine (Health Sciences)